Avik Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
- Paid Up Capital ₹ 10.88 Cr
- Company Age 45 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.43 Cr
- Satisfied Charges ₹ 19.02 Cr
- Revenue Growth 25.22%
- Profit Growth 49.19%
- Ebitda 28.50%
- Net Worth 536.70%
- Total Assets 15.80%
About Avik Pharmaceutical
Avik Pharmaceutical Limited (APL) is a leading Public Limited Indian Non-Government Company incorporated in India on 25 September 1979 and has a history of 45 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Avik Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 10.88 Cr.
The company currently has active open charges totaling ₹20.43 Cr. The company has closed loans amounting to ₹19.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Avik Pharmaceutical Limited India is Chandrashekar Shetty as CFO. Neha Thakore, Anant Thakore, and Jeevan Nagori serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U99999MH1979PLC021711
- Company No.
021711
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Sep 1979
- Date of AGM
12 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Avik Pharmaceutical Limited offer?
Avik Pharmaceutical Limited offers a wide range of products and services, including Inspection & Quality Check Services, Quality Inspection Service.
Who are the key members and board of directors at Avik Pharmaceutical?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrashekar Shetty  | CFO | 23-Sep-2019 | Current |
| Anant Thakore | Managing Director | 25-Sep-1979 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neha Thakore | Whole-Time Director | 22-Jul-2013 | Current |
| Jeevan Nagori | Director | 18-Nov-2013 | Current |
Financial Performance of Avik Pharmaceutical.
Avik Pharmaceutical Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.22% increase. The company also saw a substantial improvement in profitability, with a 49.19% increase in profit. The company's net worth Soared by an impressive increase of 536.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avik Pharmaceutical?
In 2023, Avik Pharmaceutical had a promoter holding of 50.00% and a public holding of 50.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neema Sales LlpNeha Thakore is a mutual person
Anantco Enterprises Private LimitedNeha Thakore and Anant Thakore are mutual person
Aether Industries LimitedJeevan Nagori is a mutual person
Anantco Pharmachem Private LimitedNeha Thakore and Anant Thakore are mutual person
- Neema Sales Private Limited
Neha Thakore is a mutual person
- Unilink Impex Private Limited
Jeevan Nagori is a mutual person
Charges (Loans)
₹20.43 Cr
₹19.02 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 20.43 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2015 | Yes Bank Limited | ₹20.43 Cr | Open |
| 21 Apr 1999 | Indian Bank | ₹12.39 Cr | Satisfied |
| 04 Mar 1998 | Central Bank Of India | ₹1.30 Cr | Satisfied |
| 28 Apr 1994 | Indian Bank | ₹2.50 M | Satisfied |
| 11 May 1991 | Indian Bank | ₹1.85 Cr | Satisfied |
How Many Employees Work at Avik Pharmaceutical?
Avik Pharmaceutical has a workforce of 174 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avik Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avik Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
